The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global surgical drainage devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Surgical drainage devices are used to remove the contents of different organs, secretion of body cavities, and blood, serum, lymph, and other tissue fluids that accumulate in wound beds after surgical procedures. These devices minimize pressure on the surgical site and adjacent organs, nerves, and blood vessels, thereby reducing pain and enhancing wound perfusion and healing. They find application in urinary catheters, nasogastric tubes, chest drainage, and infected cysts. Presently, various surgical drainage devices made using latex, silicone, polyethylene, and polyvinyl chloride (PVC) are available worldwide, depending on the patient's surgery and wound.
A significant increase in the number of surgical procedures relating to the chest, lymph node, breast, abdominal, and thyroid represents one of the key factors propelling the market growth. Surgical drainage devices facilitate the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissues. Moreover, the rising demand for plastic surgery due to the increasing willingness among individuals to undergo reconstructive and cosmetic surgeries is bolstering the market growth. Apart from this, surgical drainage devices monitor potential complications and relieve the pressure that can impair perfusion or cause pain, thereby decreasing morbidity. Consequently, the rising incidence of neurosurgery with a high risk of raised intracranial pressure and orthopedic procedures associated with blood loss is influencing the market growth. Furthermore, they are widely being adopted in veterinary practice for surgical or traumatic wound management. The rising adoption of companion animals, along with the flourishing poultry and agriculture industries, is also contributing to market growth. Additionally, the growing focus on improving the functionality and reducing complications associated with drainage devices in surgeries is anticipated to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical drainage devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acelity L.P. Inc. (3M Company), B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Cook Group Incorporated, Johnson & Johnson, Medela AG, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Teleflex Incorporated.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Acelity L.P. Inc. (3M Company), B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Cook Group Incorporated, Johnson & Johnson, Medela AG, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Teleflex Incorporated.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at